InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Stilley William B. III, Chairman & CEO. Insider active across 2 companies, notably Sysorex, Inc.. In total, 7 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €46k. Activity tracked since 3 September 2021. The latest transaction was filed on 23 May 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
240,800 shares0Common StockSEC:0001213900-23-043129:0
166,667 shares0Common StockSEC:0001213900-23-000003:0
250,000 shares0Common StockSEC:0001213900-22-009432:0
10,000 shares@ US$2.58920.78% mcap50.0% of flowCommon StockSEC:0001213900-21-062729:0
Ideal exit: 26 Aug 2022 (T+270)
10,000 shares@ US$2.589250.0% of flowCommon StockSEC:0001213900-21-062729
Ideal exit: 26 Aug 2022 (T+270)
50,000 shares0Common StockSEC:0001213900-21-047517:0
50,000 shares0Common StockSEC:0001213900-21-047517
7 of 7 declarations
About Stilley William B. III
William B. Stilley III is the Chief Executive Officer of Sysorex, Inc. and ADIAL PHARMACEUTICALS, INC. As CEO, he oversees the overall operations of the companies and is responsible for implementing the global strategy. His experience in the industry enables him to effectively lead growth and innovation initiatives within both organizations.
